Skip to main content
. Author manuscript; available in PMC: 2011 Jun 16.
Published in final edited form as: Pediatr Crit Care Med. 2010 Mar;11(2 Suppl):S41–S45. doi: 10.1097/PCC.0b013e3181d10845

Figure 4.

Figure 4

In children with pulmonary arterial hypertension associated with congenital heart disease, inhaled nitric oxide (iNO), and inhaled iloprost lowered the pulmonary vascular resistance/systemic vascular resistance ratio (Rp/Rs) compared with baseline. There was no additive effect of iNO to inhaled iloprost. Reprinted with permission from Rimensberger et al (46).